1
|
Oliván-Sasot P, La Parra-Casado C, Orozco-Molano AC, Camacho-Berne L, Peris-Conejero T, Tembl-Ferrairo A. Fatty sparing areas simulating liver metastases on 18F-FDG PET/CT. Rev Esp Med Nucl Imagen Mol 2024; 43:59-60. [PMID: 37972854 DOI: 10.1016/j.remnie.2023.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 09/21/2023] [Accepted: 09/25/2023] [Indexed: 11/19/2023]
Affiliation(s)
- P Oliván-Sasot
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain.
| | - C La Parra-Casado
- Radiodiagnóstico, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - A C Orozco-Molano
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - L Camacho-Berne
- Radiofarmacia, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - T Peris-Conejero
- Radiofarmacia, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - A Tembl-Ferrairo
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| |
Collapse
|
2
|
Oliván-Sasot P, Pérez-Enguix D, Bello-Arques P, Torres-Espallardo I, Falgás-Lacueva M, Yepes-Agudelo AM, Olivas-Arroyo C. Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases. Radiologia (Engl Ed) 2023; 65:12-21. [PMID: 36842781 DOI: 10.1016/j.rxeng.2021.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 09/30/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To contribute our results to increase the scientific evidence about the use of radioembolization in the management of patients with hepatocellular carcinoma. MATERIAL AND METHODS This retrospective review included 53 patients with hepatocellular carcinoma treated with radioembolization at our center. Patients were classified according to the BCLC algorithm in detail according to their Child-Pugh functional status. We analyzed survival using the Kaplan-Meier method. We used Cox regression analysis to determine clinically significant parameters, including the doses administered in the parameters studied. RESULTS Patients ranged in age from 28 to 86 years (mean, 60 years). A total of 61 procedures were done. The mean activity administered was 2.8GBq (0.7-6.4GBq), with a mean dose of 229.9Gy (74-425.9Gy) administered in the tumor. Progression-free survival was 6.7 months and overall survival was 12.8 months. Differences in disease-free survival according to BCLC and Child-Pugh classification were not significant (p=0.848 and p=0.252, respectively). The clinical parameters that were significantly different with respect to overall survival were bilirubin levels (p<0.001), pretreatment transaminase levels (AST) (p=0.022), Child-Pugh subclassification (p=0.003), and dose administered in the tumor (p=0.001). Only one patient had a severe adverse reaction, developing posttreatment liver failure resulting in death. CONCLUSIONS Radioembolization is safe and efficacious in the treatment of patients with hepatocellular carcinoma. Liver function and the doses received by the tumor are key parameters for the efficacy of treatment. The increase in the scientific evidence supports the inclusion of this technique in treatment guidelines.
Collapse
Affiliation(s)
- P Oliván-Sasot
- Medicina Nuclear, Hospital de La Ribera, Alzira, Valencia, Spain.
| | - D Pérez-Enguix
- Radiología Intervencionista, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - P Bello-Arques
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | | | - M Falgás-Lacueva
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - A M Yepes-Agudelo
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - C Olivas-Arroyo
- Radiofarmacia, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| |
Collapse
|
3
|
Oliván-Sasot P, Ipiens-Escuer C, Orozco-Molano AC, Azzi H, Camacho-Berne L, Tembl-Ferrairo A. Brain perfusion SPECT in Alice in Wonderland syndrome. Rev Esp Med Nucl Imagen Mol 2021; 41 Suppl 1:S62-S63. [PMID: 34903476 DOI: 10.1016/j.remnie.2021.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 09/27/2021] [Accepted: 09/30/2021] [Indexed: 11/30/2022]
Affiliation(s)
- P Oliván-Sasot
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain.
| | - C Ipiens-Escuer
- Neurofisiología, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - A C Orozco-Molano
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - H Azzi
- Neurofisiología, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - L Camacho-Berne
- Radiofarmacia, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| | - A Tembl-Ferrairo
- Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain
| |
Collapse
|
4
|
Oliván-Sasot P, Sánchez-Vañó R, Calvillo-Batllés P, Belda Ramirez J, Bello-Arques P. Un caso raro de captación pulmonar difusa y bilateral en 18F-FDG PET/TC. Rev Esp Med Nucl Imagen Mol 2021. [DOI: 10.1016/j.remn.2020.11.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
Oliván-Sasot P, Sánchez-Vañó R, Calvillo-Batllés P, Belda Ramirez J, Bello-Arques P. A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan. Rev Esp Med Nucl Imagen Mol 2021; 40:337-338. [PMID: 34425980 DOI: 10.1016/j.remnie.2020.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 11/08/2020] [Indexed: 10/21/2022]
Affiliation(s)
- P Oliván-Sasot
- Servicio de Medicina Nuclear, Hospital Universitario de La Ribera, Alzira, Valencia, Spain.
| | - R Sánchez-Vañó
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - P Calvillo-Batllés
- Servicio de Radiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - J Belda Ramirez
- Servicio de Neumología, Hospital Arnau de Vilanova, Valencia, Spain
| | - P Bello-Arques
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| |
Collapse
|
6
|
Oliván-Sasot P, Pérez-Enguix D, Bello-Arques P, Torres-Espallardo I, Falgás-Lacueva M, Yepes-Agudelo AM, Olivas-Arroyo C. Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases. Radiologia (Engl Ed) 2020; 65:S0033-8338(20)30143-0. [PMID: 33257052 DOI: 10.1016/j.rx.2020.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 09/10/2020] [Accepted: 09/30/2020] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To contribute our results to increase the scientific evidence about the use of radioembolization in the management of patients with hepatocellular carcinoma. MATERIAL AND METHODS This retrospective review included 53 patients with hepatocellular carcinoma treated with radioembolization at our center. Patients were classified according to the BCLC algorithm in detail according to their Child-Pugh functional status. We analyzed survival using the Kaplan-Meier method. We used Cox regression analysis to determine clinically significant parameters, including the doses administered in the parameters studied. RESULTS Patients ranged in age from 28 to 86 years (mean, 60 years). A total of 61 procedures were done. The mean activity administered was 2.8 GBq (0.7-6.4 GBq), with a mean dose of 229.9Gy (74-425.9Gy) administered in the tumor. Progression-free survival was 6.7 months and overall survival was 12.8 months. Differences in disease-free survival according to BCLC and Child-Pugh classification were not significant (p=0.848 and p=0.252, respectively). The clinical parameters that were significantly different with respect to overall survival were bilirubin levels (p<0.001), pretreatment transaminase levels (AST) (p=0.022), Child-Pugh subclassification (p=0.003), and dose administered in the tumor (p=0.001). Only one patient had a severe adverse reaction, developing posttreatment liver failure resulting in death. CONCLUSIONS Radioembolization is safe and efficacious in the treatment of patients with hepatocellular carcinoma. Liver function and the doses received by the tumor are key parameters for the efficacy of treatment. The increase in the scientific evidence supports the inclusion of this technique in treatment guidelines.
Collapse
Affiliation(s)
- P Oliván-Sasot
- Medicina Nuclear, Hospital de La Ribera, Alzira, Valencia, España.
| | - D Pérez-Enguix
- Radiología intervencionista, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - P Bello-Arques
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | | | - M Falgás-Lacueva
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - A M Yepes-Agudelo
- Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - C Olivas-Arroyo
- Radiofarmacia, Hospital Universitario y Politécnico La Fe, Valencia, España
| |
Collapse
|
7
|
Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C, Muñoz-Langa J. Quantitative assessment is essential for interpreting lymphoscintigraphy: Response to Ramin Sadeghi's letter to the editor. Rev Esp Med Nucl Imagen Mol 2019. [DOI: 10.1016/j.remnie.2018.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C, Muñoz-Langa J. La evaluación cuantitativa es esencial para la interpretación de la linfogammagrafía: respuesta a la carta al editor de Ramin Sadeghi. Rev Esp Med Nucl Imagen Mol 2019; 38:112-113. [DOI: 10.1016/j.remn.2018.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Revised: 12/05/2018] [Accepted: 12/10/2018] [Indexed: 11/24/2022]
|
9
|
Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C, Muñoz-Langa J. Hallazgos linfogammagráficos en pacientes con lipedema. Rev Esp Med Nucl Imagen Mol 2018; 37:341-348. [DOI: 10.1016/j.remn.2018.06.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2018] [Revised: 06/18/2018] [Accepted: 06/26/2018] [Indexed: 10/28/2022]
|
10
|
Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C, Muñoz-Langa J. Lymphoscintigraphic findings in patients with lipedema. Rev Esp Med Nucl Imagen Mol 2018. [DOI: 10.1016/j.remnie.2018.10.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
11
|
Oliván-Sasot P, Falgás-Lacueva M, García-Sánchez J, Vera-Pinto V, Olivas-Arroyo C, Bello-Arques P. Use of 177Lu-dotatate in the treatment of iodine refractory thyroid carcinomas. Rev Esp Med Nucl Imagen Mol 2016; 36:116-119. [PMID: 27793633 DOI: 10.1016/j.remn.2016.08.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 08/19/2016] [Accepted: 08/29/2016] [Indexed: 11/29/2022]
Abstract
In a patient with a differentiated thyroid cancer the standard treatment protocol to be followed is surgery, ablation of thyroid remnants with 131Iodine (131I), and TSH suppression. However, the treatment with 131I is not effective in some cases, and it no longer becomes a therapeutic option due to cell de-differentiation with loss of 131I uptake. Systemic treatment can be used as other options, although patients are not always responsive; thus, the disease may progress and therapeutic options may run out. Endocrine tumours may express somatostatin receptors,and this characteristic has been used, not only for diagnosis, but also for their treatment through somatostatin analogue labelling with radioactive isotopes. This was the case of a patient suffering from iodine-refractory follicular thyroid carcinoma, with somatostatin receptors expression, treated with 177Lu-DOTATATE, showing an excellent clinical and analytical response.
Collapse
Affiliation(s)
- P Oliván-Sasot
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España.
| | - M Falgás-Lacueva
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - J García-Sánchez
- Servicio de Oncología Médica, Hospital Arnau de Vilanova, Valencia, España
| | - V Vera-Pinto
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - C Olivas-Arroyo
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| | - P Bello-Arques
- Servicio de Medicina Nuclear, Hospital Universitario y Politécnico La Fe, Valencia, España
| |
Collapse
|